Effect and safety of minoxidil

Can minoxidil promote hair growth? The results show that it is entirely possible. Using minoxidil for 12 months, all 102 participants achieve significant results in hair growth. 84% of the patients have moderate or dense hair growth. Even taking into account all subjects, its response rate is over 68%. Is the hair growth meaningful or just a surface phenomenon? The further study shows that it is meaningful for 84% of cases to do continuous tests. But some cases give up the trial because. They believe that the hair is no longer fall off or grows slow. Hairs of 22% of subjects become thicker. There are 54 patients who are very enthusiastic to continue to use minoxidil. The efficiency rate is about 54%.

In 12 months, minoxidil maintains at a level of 2.7ng/ml. But cosmetic raw material suppliers find out that it is not the highest data. But we can thus see that the body's absorption, minoxidil has not been that the non-androgen in the body. For patients with a high degree of ideological burden, decreased libido is not a serious problem, such issues to interrupt the use of minoxidil and later may disappear within 48 hours after 72 hours of interrupted hormonal assessment, although this estimate is a rough prediction of the hormone content of reducing situation, but it does not explain its content is lower than normal levels, these studies can not exist in sexual desire and topical minoxidil because of a causal relationship can not prove the role of the Non-androgen. But these phenomena are indeed in line with the symptoms of drug’s side effects.

Do only those people who have only alopecia in short time get the maximum benefits through the use of minoxidil? For subjects who continue to use minoxidil, some patients whose alopecia time is no more than four years also made a good effect, some people use minoxidil thereafter, the second year of the hair growth faster in the first year, but some effects can not be satisfactory in the second year. The second year in a good effect, and can not explain because the population increase in the concentration of minoxidil alopecia duration can not be as favorable or unfavorable effect of projections are based on, for the vast majority of patients choose to continue to test a is not the end of the reaction. Some reaction is somewhat special in a way, patience is mainly determined by the physician and patient, topical minoxidil can be observed in the four months the possibility of significant hair growth is rarely used. After one year use, some of the effects may emerge. If people use it in more than one year, it is no doubt for them to get very satisfactory results.

How to interpret the first four months of treatment the placebo response? Terminal hair growth slightly slower than in the placebo group to study the first four months of active treatment group. But the experimental data from minoxidil supplier shows that the placebo group lacks of effectiveness.

How about the security of topical use of minoxidil? Two subjects have atopic dermatitis and other four people have scalped itching. These smaller negative impacts can be considered as side effects of topical minoxidil. Short-term skin edema can occur in some subjects. But it is more obviously related with diet than the drugs. There are no significant changes of pulse and blood pressure. But the sexual and impotence for two subjects can not be explained. The symptoms may be related to psychological factors. In looking for an objective standard, it should be cautious and serious.

Source:http://www.cosprm.com

Five common issues in docetaxel

How about characteristics of clinical application of docetaxel injection? Docetaxel’s clinical applications are characterized by its pharmacological effects. Docetaxel is a paclitaxel antitumor drug. It plays anti-tumor role its roles by interfering with cell microtubule network which is necessary for mitosis and interphase cell function. Docetaxel can combine with the free tubulin to promote tubulin assembly into stable microtubules. Meanwhile, it inhibits the depolymerization, resulting in production and fixation of microtubules which is in loss of normal function. Thus it inhibits cell mitosis. Combination of docetaxel with microtubule does not change the number of the original wire. The point is different with the most of spindle toxicity drugs which are applied in clinical trials. In hospitals or pharmacies, docetaxel price is acceptable.

Which kind of disease is docetaxel injection suitable for? Docetaxel is suitable for the treatment of the selection of failure of chemotherapy in advanced or metastatic non-small cell lung cancer. Unless a clinical contraindication, the initial treatment should including the anti-cancer drugs. Docetaxel is also used in the treatment of advanced or metastatic non-small cell lung cancer when there is a failure in cisplatin-based chemotherapy.

Why erythemas occur on hands and feet after people use docetaxel? Docetaxel has adverse reactions on skin. It often shows the formation of erythema and it is mainly seen in the hands, feet. It may also occur in the local arm, face and chest rash, sometimes accompanied by itching. The rash may often be in the infusion Dorsey him after the game within a week, but may recover before the next infusion.

What issues need people’s attention in use of docetaxel? Docetaxel must be used in cancer chemotherapy drug application experience under the guidance of a doctor. Leukocyte count of patients less than 1500/m3 disabled. Pregnancy, lactating women and children disabled. Before the treatment, patients should take glucocorticoids such as dexamethasone, in order to reduce the incidence of fluid retention. In opinions of pharmaceutical raw materials suppliers and researchers, during the treatment period, patients should regularly monitor the number of blood cells.

How about docetaxel’s metabolism process and absorption situation in the body? Docetaxel has its metabolism in hepatic. It is mainly duct from feces through the bile. While urinary excretion only accounts for 5% to 7%. For patients with abnormal liver function, the clearance rate of docetaxel reduces in vivo.  But the age difference will not make significant change for docetaxel’s drug activity in human body.

Souce:http://www.cospcn.com

Metabolism of carotene and astaxanthin synthesis

Scientists have a study in scenedesmus obliquus. They analysis the carotenoid accumulation in algal cells and astaxanthin synthesis. Meanwhile, they involve in study of cell morphology, structure and physiological changes in carotenoid synthesis and metabolism processes. They also discuss about the function of astaxanthin in the cells. The main findings are as follows. In addition, patients and their family members can get astaxanthin price from the internet and hospitals.

There are two steps to cultivate scenedesmus obliquus to induce carotenoid accumulation. The specific inducing conditions include: the nitrogen concentration of 0.75g / L, the light intensity of 180μmol m-2 s-1, temperature of 35 ° C, salt concentration 0.4g / L, pH value is maintained at 7. Analysis showed that the carotenoid composition in the cells of Scenedesmus obliquus, including lutein, a new flavin-born carotenoids and sea urchins ketone, canthaxanthin, 3'-hydroxy-sea urchin ketone, marigold flavin, marigold red factors and astaxanthin and secondary carotenoids. Intracellular astaxanthin biosynthetic pathway from β-carotene into canthaxanthin or 3'-hydroxyl sea urchin ketone by sea urchins ketone, canthaxanthin and then converted to the marigold red pigment; 3'-hydroxy sea urchin ketone can be transformed into red pigment of marigold or calendula flavin; marigold red pigment and marigold flavin eventually turned into a three biosynthetic pathway for astaxanthin; Astaxanthin synthesis process, chlorophyll, lutein and flavin content decreased, and changes in the content of chlorophyll and astaxanthin content was negatively correlated.

After the removal of the stress conditions, the intracellular pigment composition has also changed. The secondary carotenoids hydrolysis of astaxanthin monomer disappeared, only detected astaxanthin ester; including sea urchins ketone, canthaxanthin and marigold red pigment astaxanthin precursors have undergone hydrolysis. Born carotenoids such as chlorophyll and lutein again become the main component of the pigment. According to the experimental results, it infers that astaxanthin has three ways in the metabolic process: The first part is esterified to generate astaxanthin monoester or diester; together with most of the secondary carotenoid algal cells in some way re-use: three along the path of the similar xanthophyll cycle, reverse synthesis of lutein in photosynthesis.

The photosynthetic physiology of the cell has changed greatly in the process of the cells to synthesize astaxanthin. However, when experimental conditions change, remove stress, the photosynthetic activity of cells is reversed. Accompanied by the hydrolysis of secondary carotenoids, photosynthetic rate of the cells was even higher than the initial level stress; a strong reduction of cell respiration rate, only 3.98μmol • O2 • mg the-1chla • h-1. Changes of the photosynthetic activity of these two processes in the cell showed that the secondary carotenoids and astaxanthin of cells with light protection can reduce the photosynthetic activity through the barrier effect against high light damage.

Cells by light microscopy and electron microscopy, cell morphology and structure have undergone significant changes. The normal growth of scenedesmus obliquus is stereotyped groups of four or eight cells, the cells were spindle-shaped. Single or two cell groups in the process of accumulation of secondary carotenoids, the cells begin to become round or oval; cell color from green to yellow or brown. The cell ultrastructure of the biggest changes is the formation of a large number of fat body and gradually occupied most of the intracellular space; the fat body of the nucleus, chloroplasts and other organelles are wrapped up, and transferred to the cell center or the side. In the whole process, the chloroplast and thylakoid structure, morphology remain intact. This shape change is reversible, with the hydrolysis of the fat body, cell morphology and structure of the gradual return to normal. This change also shows that cosmetics material astaxanthin has a physical protective effect for organelles especially chloroplast.

Algal cells, accumulates carotenoids. At the same time, growth and proliferation are also affected. The experimental results show that dry weight of the cells in stress increased by 18.9% within 48 hours. It is much higher than normal growth cells in the same period. The intracellular protein and RNA levels are decreased in varying degrees. And it is significantly lower than normal growth of cells, thus indicating that growth is inhibited. The cell numbers and the intracellular DNA content appeared to decline and it is lower than the control group cells. When conditions change, hydrolysis of secondary carotenoids occurs and these physiological processes are recovered. These results suggest that normal cell division and proliferation are inhibited by stress conditions. The increasing of cell volume and dry weight is closely related with accumulation of astaxanthin in carotenoid.

Source:http://www.cosprm.com

Extraction condition and thinking of plant extracts

With the development of society, the medical model has been changed from the mere treatment of disease into the combination mode of prevention, care and treatment. Drugs whose raw material is plant extracts have achieved significant results in treatment of the disease around the world since the 1970s. It increases people’s awareness of plant extracts. Meanwhile, chemical synthetic drugs have adverse reactions and side effects. With the increasing depth and breadth of international pharmaceutical market after China's accession to the WTO, plant extract is the key to promote the modernization of Chinese medicine and technological innovation. Plant extracts is bound to become one of the most popular drugs in the 21st century.

Chinese plant extracts industry has formed certain scale, although some well-known large enterprises, but a lot of proprietary Chinese medicine, fine chemical manufacturer producing plant extracts, but the scale, the export volume of the larger companies of not more than . The scale of production of plant extracts has some progress, but from the modern scale, there is a considerable gap. Manufacturer’s herd, duplication of investment, resulting in waste of resources is not conducive to the development of enterprise scale.

Meanwhile, plant extract supplier is not well known by people. The products do not have brands in the international market. In the development of plant extracts in China, only a handful of companies have a certain reputation in the international market. But no one of them really has its brand. Technological content of products is low, vulnerability to market shocks, to bring the marketing difficulties. Compared with foreign products, the quality of plant extracts is not high, prices are generally low. No quality assurance of the low-price competition between manufacturers of plant extracts, not only disturbed the market also smashed name of the product's brand; Secondly, the certain product rush into mass action, between enterprises to keep the prices down, shoddy products vicious competition still exists. In addition, the export plant extract pesticide residues, heavy metals, microbial limit exceeded phenomenon. Even if the international market is the future of the plant extracts market demand for full, but the low level of supply is still difficult to meet the quality requirements.         

China should set the quality standards of the plant extracts to improve product quality to develop in line with Chinese characteristics, scientific, modern plant extracts internationally recognized quality standards, to ensure that the plant extracts, safe, effective, quality control. At present, only Ginkgo biloba extract a small amount of quality standards, the vast majority of plant extracts there is no national quality standards, the majority of enterprises is the basis of the quality of provisions in the contract as a product delivery and product quality testing methods confusion. Companies can not use the accumulated production itself in the international market supply, quality control experience for foreign manufacturers of pharmaceutical preparations services, thereby eroding the international competitiveness of enterprises.

Chinese pharmaceutical raw materials suppliers should strengthen the support of well-known brand products and final product development work. The government should have national strategic objectives to guide the direction of the modernization of Chinese medicine,. With the integration of universities, research institutions, pharmaceutical companies, and many other forces, it will create a good development environment to build a research and development system. Strengthen research on the international market to help enterprises develop new markets, promote exports. Strengthening foreign exchange, the use of ism, and plant extracts into the world to make unremitting efforts to jointly promote the modernization of Chinese medicine development.

Standardization and large-scale production of plant extracts are important parts in promoting the modernization of Chinese medicine. It becomes an effective way for Chinese medicines enter into the international market. With the status of traditional medicines and herbal medicine increasing, consumers become familiar with the plant extracts. Plant extracts is becoming widely recognized by consumers. So it will unlimited development prospects in future.

Source:http://www.cospcn.com

Tretinoin and fiber proliferative disease

Tretinoin is an active metabolite of vitamin A in the body. It belongs to is vitamin A with biological functions of mediated cell proliferation, differentiation, apoptosis and immune regulation. The initial study of tretinoin is more concentrated in the tumor effects, especially for acute promyelocytic leukemia. Now it has been successfully used in clinical trials. In recent years, the kidney, liver, lung, and other appropriate animal model experiments have confirmed retinoic acid’s role in anti-fibrosis and cell proliferation. The cosmetic raw material suppliers also make the tretinoin applied in treating dermatosis of fibroblasts proliferation and excessive collagen deposition.

Tubulointerstitial fibrosis is the common pathway for a variety of chronic kidney disease to end stage renal failure. The degree of tubulointerstitial damage and glomerular filtration rate was negatively correlated with prognosis than the glomerular lesions. Classic unilateral ureteral obstruction model, given retinoic acid intervention, and 7 days after the detection of relevant indicators, the results show that retinoic acid can significantly reduce the degree of interstitial fibrosis, reducing the infiltration of mononuclear macrophages, lowered the TGF- β1 and procollagen I mRNA expression, thus contributing to the prevention and treatment of fibrosis. Many Chinese scholars have ​​research in all angles. The results show that it has a protective effect on tubulointerstitial fibrosis.

The occurrence of liver fibrosis is caused by the synthesis and degradation of extracellular matrix components imbalance in the liver. Modern studies have shown that the Ito located in the sinusoidal function of storage and metabolic VitA, collagen production in liver fibrosis cells. RA can reduce the CCl4-induced hepatic fibrosis in rats Ⅰ, type Ⅲ collagen and other extracellular matrix accumulation in the liver, inhibition of changes in fat-storing cells to myofibroblasts. In vitro experimental studies have shown that retinoic acid can inhibit Ito 3H-TdR incorporation and reduce the primary cultured fat-storing the DNA, RNA content. A recent study showed that small doses of all-trans retinoic acid by reducing the expression of chronic alcoholic liver injury in rat liver fibrogenesis factor of TGF-β1 and CTGF and Colla1 inhibit the formation of early alcoholic liver fibrosis. Seen in this light, the RA is expected to become a new drug for the treatment of liver fibrosis.

Pulmonary fibrosis is a common outcome of a variety of different causes of interstitial lung disease. In pulmonary fibrosis, the retinoic acid lowered lung fibroblast collagen expression, inhibition of fibrosis, the development. In addition, the model of lung injury in rats exposed to hyperoxia, retinoic acid can adjust a variety of fibrosing factors, such as TGF-beta1, VEGF, IL. Compared with the control group, the lesion is reduced significantly. Retinoic acid reduces the radiation-induced lung injury and provides a theoretical basis for clinical anti-fibrosis drug development by acting on the IL-6/IL-6R system.

The final pathological changes of hypertensive damage to the cardiovascular system due to cardiac myocyte hypertrophy and collagen induced myocardial hypertrophy and diastolic dysfunction, vascular smooth muscle cell proliferation caused the atherosclerosis. AtRA increased ACE2 gene expression, thereby reducing blood pressure, and to some extent, to reduce myocardial damage. Percutaneous transluminal coronary angioplasty is safe and effective methods of treatment of coronary artery disease, restenosis after also become a big problem in the cardiovascular sector. AtRA treatment group can significantly reduce damage to the neointimal area and increased lumen area. It suggests that atRA plays a role in suppression of the damaged intimal hyperplasia. If people would like to buy tretinoin, they can consult with doctors and pharmacies.

The studies from cosmetic raw material suppliers confirm that tretinoin also has a certain role on a number of fibrotic diseases, such as scar repair of traumatic skin, proliferative vitreo retinopathy and so on. Retinoic acid has some preventive effect on various types of fiber proliferative diseases. It shows a good prospect. However, these effects are mostly based on animal studies. Clinical application of the drug needs further discussion and observation about mechanism and efficacy.

Source:http://www.cosprm.com

Cardiac toxicity of anticancer drugs and control strategies

Anticancer drugs may cause cardiovascular complications such as heart failure, myocardial ischemia, hypertension and arrhythmia. Among them, heart failure is the most serious and most common cardiac toxicity. Serious cardiac toxicity can have a direct impact on the prognosis of cancer patients. So it has become a common concern for cardiologists and cancer experts. With the population aging and the increase of tumor incidence, understanding and correct handling of the cardiac toxicity of anticancer drugs is essential for the treatment of tumor patients. Pharmaceutical raw materials suppliers have paid great efforts in developing the drugs.

Anticancer drug-induced cardiomyopathy and Drug cumulative dose, the use of cycle and used in conjunction with the cardiac toxicity of chemotherapy drugs and other factors, can lead to left ventricular dysfunction (LVD) and (or) heart failure (HF). Table 1 for anticancer drugs LVD / HF incidence.

Anthracycline-induced cardiotoxicity can be divided into acute, early slow progress and late slow progress of the three types. The incidence of acute cardiac toxicity <1%, occurred immediately after the injection anthracycline manifests itself temporarily reversible acute myocardial contractility; early slow progress of cardiac toxicity was 1.6% to 2.1%, the late slow progressive cardiac toxicity, the occurrence rate of 1.6% to 5.0%. Childhood Cancer Survivor Study showed that 30 years after the end of treatment, 73% of patients will suffer from at least one chronic disease, 42% of patients suffering from severe life-threatening disease, were paralyzed or died of chronic diseases. The pathogenesis of anthracycline-induced cardiomyopathy: mitochondrial dysfunction leads to depletion of adenosine triphosphate; by the iron - and more supple than the star complex-mediated free radical lipid oxidation; reduced glutathione peroxidase. Lesion endocardial biopsy showed expansion of the sarcoplasmic reticulum, vacuolization, shedding and necrosis of myocardial fibers.

Cyclophosphamide-induced clinical manifestations of HF in asymptomatic pericardial effusion, heart failure and pericarditis, usually 1 to 10 days after the first injection of cyclophosphamide. The risk of cardiac toxicity is dose-related, but also with previous anthracycline, mitoxantrone and mediastinal radiotherapy. A retrospective analysis showed that ifosfamide combination chemotherapy, 17% of patients with cardiac toxicity. 6 to 23 days after the first injection of ifosfamide can be observed to acute HF, and may be dose related.

Based on the findings in childhood acute lymphoblastic leukemia patients, Clofarabine induced left ventricular dysfunction was 27%. Most LVD is temporary. In breast cancer patients, compared to TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (fluorouracil, doxorubicin, cyclophosphamide) program, the incidence of HF in 55 months were 1.6 % and 0.7%; follow-up of 70 months, two groups of HF incidence of 2.3% and 0.9% respectively. In other breast cancer trials, the incidence rate of HF cause by docetaxel is as high as 8 percent. In addition, docetaxel price is increasing in the pharmaceutical market.

The incidence rate of cardiac dysfunction caused by trastuzumab single-agent program is about 2% to 7%. The incidence rate combining with paclitaxel treatment is 2% to 13% of HF incidence as high as in the combined anthracycline and cyclophosphamide 27%. In one trastuzumab long-term cardiac tolerability study, the overall incidence rate of cardiac toxicity is about 28%. CMP risk factors causing by trastuzumab include age older than 50 years, critical value of left ventricular ejection fraction before treatment, a history of cardiovascular disease, chemotherapy, sequential and previously anthracycline therapy.

Source:http://www.cospcn.com

Application of biotin rhytidectomy injections in different parts of human body

Since biotin is used in wrinkle injections, it is popular among the people who love beauty. Biotin injection has a good effect and wide application yield. So it gets widely recognition. The biotin injection is also valid for other wrinkles. People can buy biotin or biotin products to maintain youthful skins.

Biotin injection is used in 18-65 year-old adult women and men with moderate to severe wrinkles or the eyebrows. The muscles of the glabellar region are the source of produce vertical glabellar wrinkles, most biotin cosmetic injection site, there are a number of successful cases in this regard. BOTOX is used in the treatment of forehead wrinkles, re-treatment interval of 3-6 months. Typically, this region needs the number of re-treatment is less than the glabellar region. According to the report, valid time is about 4 to 6 months.

BOTOX wrinkle injection improves or reduces the crow's feet to the greatest degree. People look more relaxed and it will not cause muscle fixed. Orbicularis muscle function is very important. It is the active and passive closed eyelids, it would like to completely eliminate crow's feet is not realistic. The role of the duration of generally three months. Some populations the role of sustainable four months. The first BOTOX treatment of crow's feet, the therapeutic effect continued up to 12 months, 16 weeks after the second injection. 65% of patients still maintain its efficacy.

Wrinkled nose pattern found in the nose on both sides, and radially along the sides of the nose down. Transverse wrinkles wrinkled nose pattern formation and lowering the eyebrows muscle activity identification. Ordinary wrinkles, wrinkled nose pattern originated in the nose of BOTOX injection wrinkle cosmetic treatment of wrinkled nose pattern analysis should be done before surgery to evaluate it. If there is a wrinkled nose pattern, cosmetic raw material suppliers will usually treat wrinkled nose folds and glabellar region. After three months, it needs treatment again.

Increase with age, smoking, and do all sorts of facial expressions, make the lips and the appearance of considerable change, including perioral formation of longitudinal wrinkles. The treatment of premolar region, the best combination BOTOX and laser dermabrasion and fillers. In addition, after the injection of fillers, the injection will not feel pain, thereby enhancing the cosmetic results. The chin area BOTOX wrinkles injections and dermal filler treatment effect is very good. Chin augmentation surgery, and patients expect to do laser dermabrasion, botulinum toxin injection for the treatment of this area is also good. However, the effect of laser dermabrasion on chin dent is worse than effect in other regions of the face.

A biotin rhytidectomy injection is applied to the platysma fold the treatment of young patients with good skin elasticity. It may also treat the young patients with postoperative residual folds with best results. Treatment of platysma folds and mouth muscle-lowering treatment can be taken at the same time. It can also have a joint application in dermal fillers to restore 1/3 volume of facial region.

Source:http://www.cosprm.com